![David Harel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
David Harel is the founder of I-Logix, Inc. (1987) and CytoReason Ltd. (2016), holding the title of Chief Executive Officer & Director at CytoReason Ltd. Former job includes President at Virtual OfficeWare LLC (2013).
Education includes an MBA from Carnegie Mellon University.
David Harel active positions
| Companies | Position | Start |
|---|---|---|
CytoReason Ltd.
 CytoReason Ltd. Information Technology ServicesTechnology Services Operates an artificial intelligence that develop computational model of the human body, accurate enough to start replacing animal and human trials in drug | Founder | 31/12/2015 |
Former positions of David Harel
| Companies | Position | End |
|---|---|---|
I-Logix, Inc.
 I-Logix, Inc. Information Technology ServicesTechnology Services Develops and provides system design software & solutions | Founder | - |
Virtual OfficeWare LLC
 Virtual OfficeWare LLC Packaged SoftwareTechnology Services Provides software solutions to physicians | President | - |
Training of David Harel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Logix, Inc.
I-Logix, Inc. Information Technology ServicesTechnology Services Develops and provides system design software & solutions | Technology Services |
Virtual OfficeWare LLC
Virtual OfficeWare LLC Packaged SoftwareTechnology Services Provides software solutions to physicians | Technology Services |
CytoReason Ltd.
CytoReason Ltd. Information Technology ServicesTechnology Services Operates an artificial intelligence that develop computational model of the human body, accurate enough to start replacing animal and human trials in drug | Technology Services |
- Stock Market
- Insiders
- David Harel
